DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Hepatic encephalopathy
Hepatic encephalopathy
Non-Hepatic Hyperammonaemia: an Important, Potentially Reversible Cause of Encephalopathy
Picquestion of the Week:3/09/09
Diagnosis and Management of Primary Biliary Cholangitis Ticle
Inside Liver Disease
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases 1 2 3 4 5 Keith D
Hepatic and Pancreatic Disorders Brian A
Mechanisms, Diagnosis and Management of Hepatic Encephalopathy Ravi Prakash and Kevin D
Rifaximin (Xifaxan®) PAGE: 1 of 5 REFERENCE NUMBER
Budd Chiari Syndrome- an Overview
4 Liver, Biliary System and Pancreas 4.1 Presenting Problems 4.1.1 Jaundice Ref: Davidson P
Hepatic Encephalopathy, Hepatic Myelopathy, and Acquired Hepato‐Cerebral Degeneration Luis S
"Biloma". AJR Am J Roentgenol
Xifaxan (Rifaximin)
Spontaneous Bacterial Peritonitis in Cirrhotic Patients: Predictive Factors of Recurrence and Survival
XIFAXAN® (Rifaximin) Tablets, for Oral Use Travelers’ Diarrhea Not Caused by E
Budd Chiari Syndrome New Poster.Pdf
Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: a Modified Seven-Stage Model As a Clinical Alternative to MELD
The Role of Fecal Calprotectin in Assessment of Hepatic Encephalopathy in Patients with Liver Cirrhosis
Top View
Acute Cholangitis: Does the Timing of ERCP Alter Outcomes?
A Review of Budd Chiari Syndrome
PBC Primary Biliary Cholangitis Treatment and Management
Living with Hepatic Encephalopathy (HE) What Is Hepatic Encephalopathy (HE)?
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Dise
A Case of Acute Liver Failure After Adenovirus Infection
Crohn's Disease
Hepatic Encephalopathy: Etiology, Pathogenesis, and Clinical Signs
Hepatic Encephalopathy (HE)
PRIOR AUTHORIZATION CRITERIA BRAND NAME (Generic) XIFAXAN 550MG ONLY (Rifaximin)
Impact of Liver and Pancreas Diseases on Nutritional Status
Rifaximin (Xifaxan) for Irritable Bowel Syndrome
Rifaximin (Xifaxan®)
Nonalcoholic Cirrhosis Associated with Neuropsychological Dysfunction in the Absence of Overt Evidence of Hepatic Encephalopathy
Diagnosis and Management of Hepatic Encephalopathy
Antibiotics : Anti-Infective Agents – Oral Rifaximin (Xifaxan®) Medical Policy No
The Burden of Minimal Hepatic Encephalopathy: from Diagnosis to Therapeutic Strategies
EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosisq
Hepatic Encephalopathy—A Serious Complication of Alcoholic Liver Disease
Management and Treatment of Patients with Cirrhosis and Portal Hypertension: Recommendations from The
Reviewarticle
The Gastro & Hep Report
Hepatic Encephalopathy
Hepatic Encephalopathy
XIFAXAN (Rifaximin) RATIONALE for INCLUSION in PA PROGRAM
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by AASLD and EASL
EASL Clinical Practice Guidelines: the Diagnosis and Management of Patients with Primary Biliary Cholangitisq
Rifaximin Approved for Hepatic Encephalopathy
Cirrhosis and Hepatic Encephalopathy: Prevalent, Complex, and Debilitating
Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis
Overt Hepatic Encephalopathy: Pharmacotherapy Review
Primary Biliary Cirrhosis
Acute Pancreatitis As a Precipitant of Acute-On-Chronic Liver Failure in a Patient with Underlying Hepatitis C-Related Cirrhosis 1Deepak Gunjan, 2Vishal Sharma
Frequency of Spontaneous Bacterial Peritonitis in Liver Cirrhosis Patients Having Hepatic Encephalopathy
Hepatic Encephalopathy Due to Liver Cirrhosis
Acute Liver Failure, Hepatic Encephalopathy, Hepatorenal
Budd-Chiari Syndrome : Reassessment of a Step-Wise Treatment Strategy
Recognition and Management of Spontaneous Bacterial Peritonitis
Budd-Chiari Syndrome
Acute Liver Failure Protocol 2016
Hepatic and Pancreatic Disorders
Epidemiology and Clinical Course of Primary Biliary Cholangitis in the Asia–Pacifc Region: a Systematic Review and Meta‑Analysis
Rifaximin (Xifaxan)